Generic Name: sodium hyaluronate ophthalmic
Applies to sodium hyaluronate ophthalmic: intraocular kit, intraocular liquid
Ocular side effects have included isolated reports of diffuse particulates or haziness appearing after injection of sodium hyaluronate ophthalmic (the active ingredient contained in Amvisc Plus) into the eye.  Transient postoperative increases in intraocular pressure have been observed following the use of sodium hyaluronate in anterior segment surgery.  On rare occasions, postoperative reactions including inflammation, corneal edema, and corneal decompensation have been reported.[Ref]
1. Schrader J,  Luders S,  Kulschewski A, et al. "Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*" J Hypertens 24 (2006): 541-548
Not all side effects for Amvisc Plus may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.
